Literature DB >> 20560578

Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).

Ji Young Kim1, Ju Yeon Park, Oh Yoen Kim, Bo Mi Ham, Hyun-Jin Kim, Dae Young Kwon, Yangsoo Jang, Jong Ho Lee.   

Abstract

Obesity is currently epidemic in many countries worldwide and is strongly related to diabetes and cardiovascular disease. This study investigated the differences in metabolomic profiling between overweight/obese and normal-weight men. Overweight/obese (n=30) and age-matched, normal-weight men (n=30) were included. Anthropometric parameters, conventional metabolites, and biomarkers were measured. Metabolomic profiling was analyzed with UPLC-Q-TOF MS. Overweight/obese men showed higher levels of HOMA-IR, triglycerides, total cholesterol, and LDL-cholesterol, and lower levels of HDL-cholesterol and adiponectin than lean men. Overweight/obese men showed higher proportion of stearic acid and lower proportion of oleic acid in serum phospholipids. Additionally, overweight/obese individuals showed higher fat intake and lower ratio of polyunsaturated fatty acids to saturated fatty acids. We identified three lyso-phosphatidylcholine (lysoPC) as potential plasma markers and confirmed eight known metabolites for overweight/obesity men. Especially, overweight/obese subjects showed higher levels of lysoPC C14:0 and lysoPC C18:0 and lower levels of lysoPC C18:1 than lean subjects. Results confirmed abnormal metabolism of two branched-chain amino acids, two aromatic amino acids, and fatty acid synthesis and oxidation in overweight/obese men. Additionally, the amount of dietary saturated fat may influence the proportion of saturated fatty acids in serum phospholipids and the degree of saturation of the constituent acyl group of plasma lysoPC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20560578     DOI: 10.1021/pr100101p

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  97 in total

1.  Comparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and Liver.

Authors:  Serena Abbondante; Kristin L Eckel-Mahan; Nicholas J Ceglia; Pierre Baldi; Paolo Sassone-Corsi
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

2.  The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity.

Authors:  H-H Chen; Y J Tseng; S-Y Wang; Y-S Tsai; C-S Chang; T-C Kuo; W-J Yao; C-C Shieh; C-H Wu; P-H Kuo
Journal:  Int J Obes (Lond)       Date:  2015-04-24       Impact factor: 5.095

3.  Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals.

Authors:  Huanzi Zhong; Chao Fang; Yanqun Fan; Yan Lu; Bo Wen; Huahui Ren; Guixue Hou; Fangming Yang; Hailiang Xie; Zhuye Jie; Ye Peng; Zhiqiang Ye; Jiegen Wu; Jin Zi; Guoqing Zhao; Jiayu Chen; Xiao Bao; Yihe Hu; Yan Gao; Jun Zhang; Huanming Yang; Jian Wang; Lise Madsen; Karsten Kristiansen; Chuanming Ni; Junhua Li; Siqi Liu
Journal:  Gigascience       Date:  2017-07-01       Impact factor: 6.524

4.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Authors:  J Barr; J Caballería; I Martínez-Arranz; A Domínguez-Díez; C Alonso; J Muntané; M Pérez-Cormenzana; C García-Monzón; R Mayo; A Martín-Duce; M Romero-Gómez; O Lo Iacono; J Tordjman; R J Andrade; M Pérez-Carreras; Y Le Marchand-Brustel; A Tran; C Fernández-Escalante; E Arévalo; M García-Unzueta; K Clement; J Crespo; P Gual; M Gómez-Fleitas; M L Martínez-Chantar; A Castro; S C Lu; M Vázquez-Chantada; J M Mato
Journal:  J Proteome Res       Date:  2012-03-15       Impact factor: 4.466

5.  SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.

Authors:  Tuoyu Geng; Alton Sutter; Michael D Harland; Brittany A Law; Jessica S Ross; David Lewin; Arun Palanisamy; Sarah B Russo; Kenneth D Chavin; L Ashley Cowart
Journal:  J Lipid Res       Date:  2015-10-19       Impact factor: 5.922

6.  Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.

Authors:  Marion Carayol; Michael F Leitzmann; Pietro Ferrari; Raul Zamora-Ros; David Achaintre; Magdalena Stepien; Julie A Schmidt; Ruth C Travis; Kim Overvad; Anne Tjønneland; Louise Hansen; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Ursula Bachlechner; Antonia Trichopoulou; Christina Bamia; Domenico Palli; Claudia Agnoli; Rosario Tumino; Paolo Vineis; Salvatore Panico; J Ramón Quirós; Emilio Sánchez-Cantalejo; José María Huerta; Eva Ardanaz; Larraitz Arriola; Antonio Agudo; Jan Nilsson; Olle Melander; Bas Bueno-de-Mesquita; Petra H Peeters; Nick Wareham; Kay-Tee Khaw; Mazda Jenab; Timothy J Key; Augustin Scalbert; Sabina Rinaldi
Journal:  J Proteome Res       Date:  2017-08-11       Impact factor: 4.466

7.  Intervention Trials with the Mediterranean Diet in Cardiovascular Prevention: Understanding Potential Mechanisms through Metabolomic Profiling.

Authors:  Miguel Á Martínez-González; Miguel Ruiz-Canela; Adela Hruby; Liming Liang; Antonia Trichopoulou; Frank B Hu
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

8.  Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes.

Authors:  Victoria Sandler; Anna C Reisetter; James R Bain; Michael J Muehlbauer; Michael Nodzenski; Robert D Stevens; Olga Ilkayeva; Lynn P Lowe; Boyd E Metzger; Christopher B Newgard; Denise M Scholtens; William L Lowe
Journal:  Diabetologia       Date:  2016-12-16       Impact factor: 10.122

9.  Metabolites as novel biomarkers for childhood obesity-related traits in Mexican-American children.

Authors:  V S Farook; L Reddivari; G Chittoor; S Puppala; R Arya; S P Fowler; K J Hunt; J E Curran; A G Comuzzie; D M Lehman; C P Jenkinson; J L Lynch; R A DeFronzo; J Blangero; D E Hale; R Duggirala; J Vanamala
Journal:  Pediatr Obes       Date:  2014-11-18       Impact factor: 4.000

10.  The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity.

Authors:  Zora Djuric; D Kim Turgeon; Ananda Sen; Jianwei Ren; Kirk Herman; Devon Ramaswamy; Lili Zhao; Mack T Ruffin; Daniel P Normolle; William L Smith; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.